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Thalidomide, advertised in the 1950s as asafedrugfor morningsickness
in pregnancy and as a sedative, created an epidemic of 15,000 babies
worldwide with missing limbs (1). As we discovered later, thalidomide
also caused other developmental disabilities including mental retarda-
tion and autism (2,3). Graphic depictions ofchildren deformed by
thalidomide aroused the public and its elected representatives and pro-
voked new laws and regulations designed to prevent a recurrence. A
birth defects surveillance program was put into place at the Centers for
Disease Control (CDC) in Atlanta, Georgia, and continues to this
day. New drugs now undergo extended testing for their potential to
induce birth defects.
Today, 40 years later, we are coming to realize that the thalido-
mide tragedy was not an exception, but, rather, a warning. We have
come to understand that chemicals in the environment can cause a
wide range of developmental disabilities in children, and that
anatomic malformations are only the most obvious. Current concerns
especially focus on the concept that certain chemicals can cause clinical
and subclinical deficits in neurobehavioral development through
injury to the fetal brain. The implications ofsmall shifts in intelligence
quotient score and a slightly increased tendency to aggression are not
so easily conveyed or grasped as a picture of deformed limbs.
However, recognition ofthe importance ofsuch changes is gathering
momentum and is documented in this monograph.
A prime motivating force is the realization that we know the
causes offewer than 25% ofneurodevelopmental disabilities. These
disabilities, including dyslexia, attention deficit hyperactivity disorder
(ADHD), intellectual retardation, and autism, affect an estimated
3-8% ofthe 4 million babies born each year in the United States.
Some of these disorders are ofgenetic origin; some are caused by
chromosomal aberrations such as fragile X syndrome and Down syn-
drome; some are the consequence of untoward events in early life
such as perinatal anoxia and meningitis; and some result from expo-
sures in utero to drugs ofabuse such as alcohol, cocaine, heroin, and
probably nicotine. But for most neurodevelopmental disabilities, the
cause remains unknown.
A diverse assortment of toxic chemicals in the environment is
capable ofcausing neurodevelopmental disabilities. For example, ele-
vated blood lead levels and lead poisoning still affect nearly 1 million
children in the United States (4), and prenatal exposure to even rela-
tively low levels oflead result in lifelong reductions of intellectual
function and disorders ofbehavior (5,6). Polychlorinated biphenyls
(PCBs) are distributed widely in the environment and cross the
placenta to cause in uteroinjury to the developing brain (7,8). Organic
mercury compounds are among the most potent developmental neu-
rotoxicants (9,10). Certain pesticides are documented to induce prena-
tal brain injury in rodent species and to result in functional deficits
(11,12); the possibility that they produce similar effects in humans
helped spur passage, in 1996, ofthe Food Quality ProtectionAct (13).
Little information on possible toxic potential is available for the
80,000 chemicals registered today with the U.S. Environmental
Protection Agency (EPA). Of the 3,000 chemicals produced or
imported at over 1 million pounds a year, only 43% have received
even minimal toxicologic assessment, and a mere 23% have been
tested to determine whether they have the potential to cause develop-
mental damage (14). In the words of pediatrician Herbert L.
Needleman, "We are conducting a vast toxicologic experiment in our
society, in which our children and our children's children are the
experimental subjects" (15).
We are faced with two major unanswered questions. First, to what
extent do chemicals in the environment cause neurodevelopmental
disabilities or other developmental disorders? Second, which chemicals
in the environment in addition to lead, PCBs, and methyl mercury
can cause neurodevelopmental disabilities? These are critical questions
to address and resolve, because disabilities arising from exposure to
toxic chemicals should be preventable.
The articles published in this monograph reflect the mounting
concern that for too longwe have neglected the possibility that environ-
mental chemicals contribute to developmental disabilities in our chil-
dren. Most ofthese reports are culled from two major conferences held
in 1998 and 1999 devoted to the question ofhow children's neuro-
behavioral development is influencedbythe chemical environment.
The first of these conferences, The Role of the Environmental
Neurotoxicants on Developmental Disabilities, held at the University
of Rochester in Rochester, New York, on 23-25 September 1998,
arose from a desire to bridge the continuing disjunction between two
distinct research areas, neurotoxicology and developmental pediatrics.
Their literatures, practitioners, and approaches inhabit separate uni-
verses. The conference was designed to unite them. It convened a
group ofgovernment and university scientists and clinicians to exam-
ine the scientific basis for relationships between exposure to environ-
mental neurotoxicants and the incidence, prevalence, etiology,
severity, and pathophysiology ofdevelopmental disabilities. It also
Environmental Health Perspectives * Vol 108, Supplement 3 * June 2000 373WEISS AND LANDRIGAN
strove to join these two disparate disciplines and perspectives to examine
how they are intertwined, to identify gaps in our understanding of
their relationships, and to recommend aprogram ofresearch.
The Rochester conference represented the 20th in a series on
environmental toxicity that began in 1968 with ChemicalFallout(16).
The proceedings, published in 1969, linked two emerging environmen-
tal problems, contamination by organomercurials and organochlorines,
with two groups ofexperts-ecologists viewing the problem from one
angle and toxicologists and environmental health specialists from
another. The 20th conference, like the first, used the powerofbinocular
vision to view the problem, so to speak, in three dimensions. The pro-
ceedings were divided into four sessions: a) mental retardation: timing
and thresholds; b) endocrine dysfunction and developmental disabilities:
dose and target implications; c) attention-deficit disorder-ADHD and
learningdisabilities; and d) newhorizons: extending the boundaries.
Support for the Rochester conference came from both public and
private sources. The National Institute ofEnvironmental Health
Sciences (NIEHS), the National Institute of Child Health and
Human Development, and the EPA represented the federal govern-
ment. The conference also received grants from several foundations:
the Jennifer Altman Foundation, the Heinz Family Foundation, the
National Alliance for Autism Research, the Violence Research
Foundation, the Wacker Foundation, and theWinslow Foundation.
The second ofthese conferences helped launch a new Center for
Children's Health and the Environment at the Mount Sinai School of
Medicine. It was held in New York City on 24-25 May 1999, and
was convened specifically to consider the intersection between neu-
rodevelopmental impairment, environmental chemicals, and preven-
tion. Over 300 health scientists, pediatricians, and public health
professionals examined the growing body ofevidence linking environ-
mental toxins to neurobehavioral disorders. The conference title was
Environmental Influences on Children: Brain, Development, and
Behavior. The conference began by reviewing well-known examples of
deleterious effects ofenvironmental chemicals, including lead and
PCBs, on children's brains. The conferees then considered the poten-
tial impact ofenvironmental chemicals on neurological disorders with
particular focus on ADHD, autism, and Parkinson's disease. The
inclusion ofParkinson's disease was intended to signal the notion that
exposures in early life may have an influence on the evolution of
neurological disease in later life.
Support for the Mount Sinai conference came from the Superfund
Basic Research Program (NIEHS); The Pew Charitable Trusts; the
Institute for Health and the Environment at the University ofAlbany
School ofPublic Health; theAgency for Toxic Substances and Disease
Research (ATSDR); the Ambulatory Pediatric Association; Myron A.
Mehlman, PhD; the National Center for Environmental Assessment
(EPA); the National Center for Environmental Health (CDC); the
National Institute of Child Health and Human Development; the
Office ofChildren's Health Protection (EPA); Physicians for Social
Responsibility; The New York Academy ofMedicine; The New York
Community Trust; and theWallace Genetic Foundation.
The impact of environmental toxins on children's health has
become a topic ofmajor concern in the federal government. Eight
new research centers in children's environmental health have been
established in the past 2 years with joint funding from EPA and
NIEHS. Clinical units that specialize in the treatment ofchildren
with environmentally induced illness have been developed across the
nation with grant support from ATSDR. The American Academy of
Pediatrics has just published its Handbook ofPediatric Environmental
Health (17), the "Green Book," which is available to pediatricians
throughout theAmericas.
Children's environmental health has climbed to a critical position
as we launch the new millennium. This monograph marks a significant
milestone in the evolution ofthis emergingdiscipline.
REFERENCES AND NOTES
1. Lenz W. A short history ofthe thalidomide embryopathy. Teratology 38:203-215(1988).
2. Miller MT, Stromiand K. Thalidomide embryopathy: an insight into autism? Teratology 47:387-388
(1993).
3. Rodier PM, Ingram JL, Tisdale B, Croog VJ. Linking etiologies in humans and animal models: studies
ofautism. Reprod Toxicol 11:417-422 (1997).
4. Centers for Disease Control and Prevention. Screening Young Children for Lead Poisoning: Guidance
for State and Local Public Health Officials. Atlanta, GA:Centers for Disease Control and Prevention,
1997. h.
5. Needleman HL, Schell A, Bellinger D, Leviton A, AlIred EN. The long-term effects of exposure to low
doses of lead inchildhood: an 11-yearfollow-up report. N EngI J Med 322:83-88 (1990).
6. Needleman HL, Riess JA, Tobin MJ, Biesecker GE, Greenhouse JB. Bone lead levels and delinquent
behavior. JAMA 275:363-369 (1996).
7. Jacobson JL, Jacobson SW. Intellectual impairment in children exposed to polychlorinated biphenyls
in utero. N EngI J Med 335:783-789(1996).
8. Patandin S, Lanting Cl, Mulder PG, Boersma ER, Sauer PJ, Weisglas-Kuperus N. Effects of environ-
mental exposure to polychlorinated biphenyls and dioxins on cognitive abilities in Dutch children at
42 months of age. J Pediatr 134:33-41 (1999).
9. Burbacher TM, Rodier PM, Weiss B. Methylmercury developmental neurotoxicity: a comparison of
effects in humans and animals. Neurotoxicol Teratol 3:191-202 (1990).
10. Watanabe C, Satoh H. Evolution of our understanding of methylmercury as a health threat. Environ
Health Perspect 104(suppl 2):367-379(1996).
11. Weiss B. Pesticides as a source of developmental disabilities. Ment Retard Dev Disabil 3:246-256
(1997).
12. Eskenazi B, Bradman A, Castorina R. Exposures of children to organophosphate pesticides and their
potential adverse health effects. Environ Health Perspect 107(suppl 3):409-419(1999).
13. Food Quality Protection Actof 1996. Public Law 104-170, 1996.
14. U.S. EPA. Chemical Hazard Data Availability Study: What Do We Really Know About the Safety of
High Production Volume Chemicals? Washington, DC:U.S. Environmental Protection Agency, 1998.
15. Needleman HL. Personal communication.
16. Miller MW, Berg GG, eds. Chemical Fallout. Springfield, IL:Thomas, 1969.
17. Committee on Environmental Health, American Academy of Pediatrics. Handbook of Pediatric
Environmental Health. Elk Grove Village, IL:American Academy of Pediatrics, 1999.
374 Environmental Health Perspectives * Vol 108, Supplement 3 * June 2000